1. Home
  2. CXT vs IRON Comparison

CXT vs IRON Comparison

Compare CXT & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crane NXT Co.

CXT

Crane NXT Co.

HOLD

Current Price

$54.00

Market Cap

2.9B

Sector

Industrials

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$75.22

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXT
IRON
Founded
1855
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.9B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
CXT
IRON
Price
$54.00
$75.22
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
$73.00
$103.18
AVG Volume (30 Days)
680.6K
572.0K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
1.65%
N/A
EPS Growth
N/A
N/A
EPS
0.11
N/A
Revenue
$3,374,900,000.00
N/A
Revenue This Year
$5.75
N/A
Revenue Next Year
$4.22
$283.52
P/E Ratio
$480.55
N/A
Revenue Growth
6.13
N/A
52 Week Low
$35.71
$40.00
52 Week High
$69.00
$99.50

Technical Indicators

Market Signals
Indicator
CXT
IRON
Relative Strength Index (RSI) 70.62 52.69
Support Level $53.18 $70.29
Resistance Level $56.16 $82.65
Average True Range (ATR) 1.58 3.26
MACD -0.11 -0.42
Stochastic Oscillator 91.73 32.98

Price Performance

Historical Comparison
CXT
IRON

About CXT Crane NXT Co.

Crane NXT Co is a industrial technology company that provides proprietary and trusted technology solutions to secure, detect, and authenticate what matters to its customers. It is a pioneer in proprietary micro-optics technology for securing physical products, and its sophisticated electronic equipment and associated software leverages proprietary core capabilities with detection and sensing technologies. The company operates in two segments which are Crane Payment Innovations (CPI) and Security and Authentication Technologies.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: